Report : MEA Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)
At 3.1% CAGR, the MEA Laboratory Animal Diet Market is speculated to be worth US$ 163.53 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the MEA laboratory animal diet market was valued at US$ 137.01 million in 2022 and is expected to reach US$ 163.53 million by 2028, registering a CAGR of 3.1% from 2022 to 2028. Growing inclination toward customized diet plan for laboratory animals and rising demand for humanized mice models are the critical factors attributed to the market expansion.
Customized diets are fed to animals for a defined purpose, such as nutrient control, inducing a disease, or a dosing technique to treat disease. Customized animal diets are tailored to the research area, specific research question, and manufacturing requirements. Customized diets are often developed in collaboration with the researcher by obtaining their research purpose and inputs. This level of control on Laboratory Animal Diet allows more uniformity, reproducibility, and flexibility in nutrition studies. Customized diets consist of refined ingredients which supply one major nutrient class, such as casein, starches and sugar, fats and oils, cellulose, and then micronutrients are added according to the requirement. The levels and types of nutrients and micronutrients are manipulated according to the necessity of the research purpose. For instance, if a zinc-deficient diet is required, the casein is replaced by egg white solids, as they are low in zinc. It is highly recommended that researchers, who plan to use a custom diet for a new project, should collaborate with a trusted nutritionist. These professionals can formulate diets with specific additions or deficiencies, including diets designed to mimic human dietary intakes. Sharing a researcher’s expertise on a particular research subject, coupled with the knowledge of nutrition, ingredients, and diet manufacturing, can make a custom diet a precision tool for creating experimental conditions that answer complex research questions. Due to the ongoing research on diseases such as metabolic diseases and cancer, the preference for a customized diet is increasing compared to a standardized diet.
On the contrary, high cost of laboratory animal diets due to maintenance and wastage hurdles the growth of MEA laboratory animal diet market.
Based on diet type, the MEA laboratory animal diet market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment held 61.9% market share in 2022, amassing US$ 84.76 million. It is projected to garner US$ 100.85 million by 2028 to expand at 2.9% CAGR during 2022–2028.
Based on animal, the MEA laboratory animal diet market is segmented mouse, cat, dog, rabbit, chicken, and others. The mouse segment held 47.4% market share in 2022, amassing US$ 64.89 million. It is projected to garner US$ 77.59 million by 2028 to expand at 3.0% CAGR during 2022–2028.
Based on application, the MEA laboratory animal diet market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment held 41.8% market share in 2022, amassing US$ 57.23 million. It is projected to garner US$ 66.53 million by 2028 to expand at 2.5% CAGR during 2022–2028.
Based on end user, the MEA market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment held 53.8% market share in 2022, amassing US$ 73.76 million. It is projected to garner US$ 86.16 million by 2028 to expand at 2.6% CAGR during 2022–2028.
Based on country, the MEA laboratory animal diet market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Our regional analysis states that Saudi Arabia captured 34.0% market share in 2022. It was assessed at US$ 46.51 million in 2022 and is likely to hit US$ 54.54 million by 2028, exhibiting a CAGR of 2.7% during the forecast period.
Key players dominating the MEA laboratory animal diet market are Altromin Spezialfutter GmbH & Co. KG; Bio-Serv; Envigo; Krishna Valley Agrotech LLP; LabDiet; Research Diets Inc.; SAFE; Special Diet Services; and Specialty Feeds among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org